Automated Point-of-Care CAR T-Cell Fabrication & Democratization
MIDI’s latest White Paper describing advancements their team engineered in the biopharma fabrication space: Automated Point-of-Care CAR T-Cell Fabrication & Democratization . In particular it reveals a shift from centralized to point-of-care manufacturing and how closed system automation plays a pivotal role in making this revolutionary therapy accessible to all.
Related Reading
Blog / Artificial Intelligence (AI) / Diagnostics / Digital Health / Health Access
The Insight Series: AI & Digital Health
March 30, 2026
“The Insight Series: AI & Digital Health” features industry experts answering key questions to help inform policymakers and the public about how AI is shaping the future of care delivery. Our latest edition features Julia Strandberg, Executive Vice President, Chief Business Leader, Connected Care at Philips.
News / Health Access / Investor Relations / The MedTech Conference
AdvaMed® and Informa’s LSX Portfolio Announce Strategic Global Partnership to Advance Medtech Innovation and Collaboration
March 17, 2026
WASHINGTON—AdvaMed®, The Medtech Association®, today announced a strategic event partnership with Informa, the global events leader and owner of the LSX portfolio of life sciences conferences, to strengthen collaboration across leading medtech convenings in the United States, Europe, and Asia-Pacific.
Event / Digital Health
Expanding Service Margins While Protecting Clinical Availability
March 26, 2026
11:30 AM – 12:30 PM
Join Genpact as they help Medtech Service leaders tackle the margin challenge by transitioning to a Predictive Triage & Guaranteed Uptime model.
News / Diagnostics / Health Access / Medical Imaging
AdvaMed® Announces Opening Nominations for its 2026 Lifetime Achievement, Dx Lifetime of Leadership & Service, and theAdvaMed® Imaging Röntgen Awards
March 4, 2026
WASHINGTON—AdvaMed® announced today that nominations for its 2025 Lifetime Achievement Award as well as the AdvaMedDx Lifetime of Leadership & Service Award and theAdvaMed® Imaging Röntgen Award are open through April 10. All three of these annual awards will be presented during The MedTech Conference, Oct.18-21, 2026, in Boston.
Resource / Digital Health / Government & Legislative Affairs
AdvaMed® 2025 Membership Has Its Privileges: Advocacy Wins for Medtech Members
March 3, 2026
AdvaMed® 2025 Membership Has Its Privileges highlights major legislative and regulatory wins delivering millions in savings and new revenue for members.
Resource / Artificial Intelligence (AI) / Coverage & Payment / Digital Health / Regulatory Affairs
AdvaMed® Comment Letter to ASTP/ONC: Accelerating AI Adoption in Clinical Care
February 24, 2026
AdvaMed’s® Comment Letter to ASTP/ONC, outlines concrete policy reforms across FDA oversight, CMS payment pathways, and HIPAA data-sharing rules to accelerate patient access to AI-enabled medical technologies. As AI-enabled medical devices transform patient care, outdated regulatory, coverage, and privacy frameworks are slowing the pace of adoption.
News / Diabetes / Digital Health
Dexcom’s Jake Leach Named Chair of AdvaMed’s Diabetes Sector
February 23, 2026
WASHINGTON—AdvaMed, the MedTech Association®, today announced that Jacob “Jake” Leach, President and Chief Executive Officer at Dexcom, will serve as the next chair of theAdvaMed® Diabetes Sector, succeeding Chris Scoggins, Executive Vice President of Diabetes Care at Abbott. TheAdvaMed® Diabetes Sector represents the world’s leading companies producing technology across the spectrum of diabetes care.
Blog / Diagnostics / Digital Health / Government & Legislative Affairs / Health Access
Heart Month: Why Sleep Apnea Belongs at the Center of Cardiovascular Care
February 13, 2026
February is American Heart Month—a time to spotlight cardiovascular disease and highlight innovations that can improve patient outcomes. For the medtech community, it’s an opportunity to address persistent gaps in care through technology, data, collaboration, and policy advancement. Despite progress in treating heart conditions, sleep disorders—especially sleep apnea—remain a significant and underrecognized contributor to poor cardiovascular outcomes.1 Tackling this issue requires clinical awareness and supportive policies for timely diagnosis, coverage, and care beyond traditional settings.